Benzinga | Jan 4, 2022 07:58AM EST

Axcella Therapeutics To Present At HC Wainwright BioConnect Conference Jan 10, 2022 At 7 a.m. EST

Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced that President and Chief Executive Officer Bill Hinshaw will be presenting at the H.C. Wainwright BioConnect Conference.

A webcast of this presentation will be available on the "Investors & News" section of the company's website, www.axcellatx.com, at 7:00 a.m. ET on January 10, 2022. A replay will be accessible on Axcella's website for 90 days following the event.